Sirolimus Use in Angioplasty for Vascular Access Extension

NCT01595841 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

End Stage Renal Disease
Venous Stenosis

Interventions

DRUG: Sirolimus

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Collaborators

[object Object]